AbCellera Biologics
ABCL
ABCL
190 hedge funds and large institutions have $1.17B invested in AbCellera Biologics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 75 increasing their positions, 37 reducing their positions, and 15 closing their positions.
Holders
190
Holders Change
+29
Holders Change %
+18.01%
% of All Funds
3.29%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
44
Increased
75
Reduced
37
Closed
15
Calls
$49.9M
Puts
$11.1M
Net Calls
+$38.9M
Net Calls Change
+$22.4M
Top Buyers
| 1 |
1
VOYA Investment Management
Atlanta,
Georgia
|
$107M |
| 2 |
2
D.E. Shaw & Co
New York
|
$27.4M |
| 3 |
CS
3
Credit Suisse
Zurich,
Switzerland
|
$40.6M |
| 4 |
CC
4
Casdin Capital
New York
|
$16.3M |
| 5 |
5
BlackRock
New York
|
$124M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GWM
201
Geneos Wealth Management
Englewood,
Colorado
| – | -$107K | -10,087 | Closed |
|
|
WAM
202
Worth Asset Management
Dallas,
Texas
| – | -$40K | -3,750 | Closed |
|
203
Rockefeller Capital Management
New York
| – | -$5K | -500 | Closed |
|
|
SWM
204
Spire Wealth Management
Mclean,
Virginia
| – | -$1K | -55 | Closed |
|